Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony L J Raviele

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Biochemical Society Transactions|November 10, 2015
Sustained NRF2 activation in hereditary leiomyomatosis and renal cell cancer (HLRCC) and in hereditary tyrosinemia type 1 (HT1)Ivraj Singh Sandhu, Nicholas James Maksim, Eva Alice Amouzougan, et al.
American Journal of Nephrology|September 14, 2020
Genotype-Guided Hydralazine TherapyKimberly S Collins, Anthony L J Raviele, Amanda L Elchynski, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Biochemical Society Transactions|November 10, 2015
Sustained NRF2 activation in hereditary leiomyomatosis and renal cell cancer (HLRCC) and in hereditary tyrosinemia type 1 (HT1)Ivraj Singh Sandhu, Nicholas James Maksim, Eva Alice Amouzougan, et al.
American Journal of Nephrology|September 14, 2020
Genotype-Guided Hydralazine TherapyKimberly S Collins, Anthony L J Raviele, Amanda L Elchynski, et al.
Pageof 1